$MCVT
Mill City Ventures III, Ltd Stock $mcvt

$mcvt Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000165495423014555 Filed on November 17, 2023

Income Statement

Concept	2023 Q4	2023 Q3
Revenue	$802.0K	$303.8K
YoY Change	-5.38%	-570.49%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$835.4K	$421.4K
YoY Change	67.16%	-62.81%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$835.4K	$421.4K
YoY Change	67.16%	-64.28%
Operating Profit
YoY Change
Interest Expense	-$1.271M	$0.00
YoY Change	52.76%	-100.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$1.304M	$306.0K
YoY Change	169.39%	-573.84%
Income Tax	-$416.6K	-$63.60K
% Of Pretax Income		-20.79%
Net Earnings	-$887.7K	$369.6K
YoY Change	180.7%	-1122.86%
Net Earnings / Revenue	-110.7%	121.65%
Basic Earnings Per Share		$0.06
Diluted Earnings Per Share	-$0.14	$0.06
COMMON SHARES
Basic Shares Outstanding	6.385M shares	6.185M shares
Diluted Shares Outstanding		6.358M shares

Balance Sheet

Concept	2023 Q4	2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$376.0K	$962.9K
YoY Change	-65.49%	-48.28%
Cash & Equivalents	$376.0K	$962.9K
Short-Term Investments
Other Short-Term Assets	$165.3K	$217.4K
YoY Change	235.84%	86.93%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$1.056M	$1.649M
YoY Change	-35.62%	-47.92%
LONG-TERM ASSETS
Property, Plant & Equipment	$9.280K	$14.72K
YoY Change	-43.41%	-31.73%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$322.9K	$1.259M
YoY Change	-77.3%	742.9%
Other Assets	$757.0K	$397.0K
YoY Change	276.62%	9825.0%
Total Long-Term Assets	$18.05M	$17.97M
YoY Change	6.65%	-0.67%
TOTAL ASSETS
Total Short-Term Assets	$1.056M	$1.649M
Total Long-Term Assets	$18.05M	$17.97M
Total Assets	$19.11M	$19.62M
YoY Change	2.91%	-7.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$71.70K	$124.1K
YoY Change	-47.48%	-7.4%
Accrued Expenses	$444.7K	$14.72K
YoY Change	2585.57%	-90.22%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$516.4K	$138.8K
YoY Change	237.38%	-51.21%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change		-100.0%
Other Long-Term Liabilities	$0.00	$0.00
YoY Change	-100.0%
Total Long-Term Liabilities	$0.00	$0.00
YoY Change	-100.0%	-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$516.4K	$138.8K
Total Long-Term Liabilities	$0.00	$0.00
Total Liabilities	$516.4K	$138.8K
YoY Change	131.35%	-94.66%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.160M	-$1.160M
YoY Change	0.0%	0.0%
Common Stock	$1.467M	$1.473M
YoY Change	11906.5%	11955.87%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$18.59M	$19.48M
YoY Change
Total Liabilities & Shareholders Equity	$19.11M	$19.62M
YoY Change	2.91%	-7.71%

Cashflow Statement

Concept	2023 Q4	2023 Q3
OPERATING ACTIVITIES
Net Income	-$887.7K	$369.6K
YoY Change	180.7%	-1122.86%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$586.8K	-$560.8K
YoY Change	-138.08%	-81.6%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	424.0K
YoY Change	-100.0%	-90.09%
NET CHANGE
Cash From Operating Activities	-586.8K	-560.8K
Cash From Investing Activities
Cash From Financing Activities	0.000	424.0K
Net Change In Cash	-586.8K	-136.8K
YoY Change	-23.99%	-111.1%
FREE CASH FLOW
Cash From Operating Activities	-$586.8K	-$560.8K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Investment Company Distribution To Shareholders Per Share InvestmentCompanyDistributionToShareholdersPerShare	0.11
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	111111111	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6385255	shares
	dei	Entity Central Index Key EntityCentralIndexKey	0001425355
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 205
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	111111111	shares
CY2022Q4	us-gaap	Common Stock Held By Subsidiary CommonStockHeldBySubsidiary	0	usd
CY2023Q3	mcvt	Fair Value Warrants FairValueWarrants	0	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	0	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	870000	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	870000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.00
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.00
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.11
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.11
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	0	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	0	usd
CY2022Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.045	pure
CY2023Q2	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	3.02
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6185255	shares
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-41472
	dei	Entity Registrant Name EntityRegistrantName	MILL CITY VENTURES III, LTD.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MN
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	90-0316651
	dei	Entity Address Address Line1 EntityAddressAddressLine1	1907 Wayzata Blvd, #205
	dei	Entity Address City Or Town EntityAddressCityOrTown	Wayzata
	dei	Entity Address State Or Province EntityAddressStateOrProvince	MN
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	55391
	dei	City Area Code CityAreaCode	952
	dei	Local Phone Number LocalPhoneNumber	479-1923
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	6385255	shares
CY2023Q3	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	17555601	usd
CY2022Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	16708432	usd
CY2023Q3	mcvt	Non Control Non Affiliate Investment At Cost NonControlNonAffiliateInvestmentAtCost	17577481	usd
CY2022Q4	mcvt	Non Control Non Affiliate Investment At Cost NonControlNonAffiliateInvestmentAtCost	17359804	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	962860	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1089641	usd
CY2023Q3	us-gaap	Notes Receivable Net NotesReceivableNet	250000	usd
CY2022Q4	us-gaap	Notes Receivable Net NotesReceivableNet	250000	usd
CY2023Q3	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	217422	usd
CY2022Q4	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	218440	usd
CY2023Q3	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	219205	usd
CY2022Q4	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	250879	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	14716	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	16398	usd
CY2023Q3	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	397000	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	201000	usd
CY2023Q3	us-gaap	Assets Assets	19616804	usd
CY2022Q4	us-gaap	Assets Assets	18734790	usd
CY2023Q3	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	124082	usd
CY2022Q4	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	776514	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	14716	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	16562	usd
CY2023Q3	us-gaap	Deferred Income DeferredIncome	0	usd
CY2022Q4	us-gaap	Deferred Income DeferredIncome	70154	usd
CY2023Q3	us-gaap	Liabilities Liabilities	138798	usd
CY2022Q4	us-gaap	Liabilities Liabilities	863230	usd
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6185255	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	12415	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	12215	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	15467091	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	15043291	usd
CY2023Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1460209	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	0	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1159665	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1159665	usd
CY2023Q3	mcvt	Accumulated Other Comprehensive Income Loss Undistributed Investment Loss AccumulatedOtherComprehensiveIncomeLossUndistributedInvestmentLoss	-1435364	usd
CY2022Q4	mcvt	Accumulated Other Comprehensive Income Loss Undistributed Investment Loss AccumulatedOtherComprehensiveIncomeLossUndistributedInvestmentLoss	-1086739	usd
CY2023Q3	mcvt	Accumulated Other Comprehensive Income Loss Undistributed Net Realized Gains Loss On Investment Transactions AccumulatedOtherComprehensiveIncomeLossUndistributedNetRealizedGainsLossOnInvestmentTransactions	5155200	usd
CY2022Q4	mcvt	Accumulated Other Comprehensive Income Loss Undistributed Net Realized Gains Loss On Investment Transactions AccumulatedOtherComprehensiveIncomeLossUndistributedNetRealizedGainsLossOnInvestmentTransactions	5713829	usd
CY2023Q3	mcvt	Stockholders Equity Unrealized Appreciation In Value Of Investments StockholdersEquityUnrealizedAppreciationInValueOfInvestments	-21880	usd
CY2022Q4	mcvt	Stockholders Equity Unrealized Appreciation In Value Of Investments StockholdersEquityUnrealizedAppreciationInValueOfInvestments	-651371	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	19478006	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	17871560	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	19616804	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	18734790	usd
CY2023Q3	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	3.05
CY2022Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	2.89
CY2023Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	725158	usd
CY2022Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	1115224	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	2496688	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	3351935	usd
CY2023Q3	us-gaap	Gross Investment Income Operating GrossInvestmentIncomeOperating	725158	usd
CY2022Q3	us-gaap	Gross Investment Income Operating GrossInvestmentIncomeOperating	1115224	usd
	us-gaap	Gross Investment Income Operating GrossInvestmentIncomeOperating	2496688	usd
	us-gaap	Gross Investment Income Operating GrossInvestmentIncomeOperating	3351935	usd
CY2023Q3	us-gaap	Professional Fees ProfessionalFees	184008	usd
CY2022Q3	us-gaap	Professional Fees ProfessionalFees	916359	usd
	us-gaap	Professional Fees ProfessionalFees	601184	usd
	us-gaap	Professional Fees ProfessionalFees	1309348	usd
CY2023Q3	us-gaap	Labor And Related Expense LaborAndRelatedExpense	141040	usd
CY2022Q3	us-gaap	Labor And Related Expense LaborAndRelatedExpense	122477	usd
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	1418640	usd
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	433461	usd
CY2023Q3	us-gaap	General Insurance Expense GeneralInsuranceExpense	26452	usd
CY2022Q3	us-gaap	General Insurance Expense GeneralInsuranceExpense	27016	usd
	us-gaap	General Insurance Expense GeneralInsuranceExpense	79974	usd
	us-gaap	General Insurance Expense GeneralInsuranceExpense	84092	usd
CY2023Q3	us-gaap	Occupancy Net OccupancyNet	14890	usd
CY2022Q3	us-gaap	Occupancy Net OccupancyNet	18589	usd
	us-gaap	Occupancy Net OccupancyNet	55005	usd
	us-gaap	Occupancy Net OccupancyNet	54542	usd
CY2023Q3	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	30000	usd
CY2022Q3	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	30000	usd
	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	592968	usd
	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	147073	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	0	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	46779	usd
	us-gaap	Interest Expense InterestExpense	78000	usd
	us-gaap	Interest Expense InterestExpense	164632	usd
CY2023Q3	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	24983	usd
CY2022Q3	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	18572	usd
	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	57464	usd
	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	34717	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	421373	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	1179792	usd
	us-gaap	Operating Expenses OperatingExpenses	2883235	usd
	us-gaap	Operating Expenses OperatingExpenses	2227865	usd
CY2023Q3	us-gaap	Net Investment Income NetInvestmentIncome	303785	usd
CY2022Q3	us-gaap	Net Investment Income NetInvestmentIncome	-64568	usd
	us-gaap	Net Investment Income NetInvestmentIncome	-386547	usd
	us-gaap	Net Investment Income NetInvestmentIncome	1124070	usd
CY2023Q3	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	0	usd
CY2022Q3	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	0	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-558629	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	133020	usd
CY2023Q3	mcvt	Net Change In Unrealized Appreciation Depreciation On Investments NetChangeInUnrealizedAppreciationDepreciationOnInvestments	2175	usd
CY2022Q3	mcvt	Net Change In Unrealized Appreciation Depreciation On Investments NetChangeInUnrealizedAppreciationDepreciationOnInvestments	0	usd
	mcvt	Net Change In Unrealized Appreciation Depreciation On Investments NetChangeInUnrealizedAppreciationDepreciationOnInvestments	629491	usd
	mcvt	Net Change In Unrealized Appreciation Depreciation On Investments NetChangeInUnrealizedAppreciationDepreciationOnInvestments	-16297	usd
CY2023Q3	us-gaap	Investment Company Realized And Unrealized Gain Loss On Investment And Foreign Currency InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency	2175	usd
CY2022Q3	us-gaap	Investment Company Realized And Unrealized Gain Loss On Investment And Foreign Currency InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency	0	usd
	us-gaap	Investment Company Realized And Unrealized Gain Loss On Investment And Foreign Currency InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency	70862	usd
	us-gaap	Investment Company Realized And Unrealized Gain Loss On Investment And Foreign Currency InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency	116723	usd
CY2023Q3	mcvt	Investment Company Net Assets From Operations Increase Decrease Before Tax InvestmentCompanyNetAssetsFromOperationsIncreaseDecreaseBeforeTax	305960	usd
CY2022Q3	mcvt	Investment Company Net Assets From Operations Increase Decrease Before Tax InvestmentCompanyNetAssetsFromOperationsIncreaseDecreaseBeforeTax	-64568	usd
	mcvt	Investment Company Net Assets From Operations Increase Decrease Before Tax InvestmentCompanyNetAssetsFromOperationsIncreaseDecreaseBeforeTax	-315685	usd
	mcvt	Investment Company Net Assets From Operations Increase Decrease Before Tax InvestmentCompanyNetAssetsFromOperationsIncreaseDecreaseBeforeTax	1240793	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-63600	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-28442	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-37922	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	346800	usd
CY2023Q3	mcvt	Investment Company Net Assets From Operations Increase Decrease Net Of Tax InvestmentCompanyNetAssetsFromOperationsIncreaseDecreaseNetOfTax	369560	usd
CY2022Q3	mcvt	Investment Company Net Assets From Operations Increase Decrease Net Of Tax InvestmentCompanyNetAssetsFromOperationsIncreaseDecreaseNetOfTax	-36126	usd
	mcvt	Investment Company Net Assets From Operations Increase Decrease Net Of Tax InvestmentCompanyNetAssetsFromOperationsIncreaseDecreaseNetOfTax	-277763	usd
	mcvt	Investment Company Net Assets From Operations Increase Decrease Net Of Tax InvestmentCompanyNetAssetsFromOperationsIncreaseDecreaseNetOfTax	893993	usd
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.06
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.18
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.06
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.18
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	18684446	usd
CY2023Q3	mcvt	Exercise Of Stock Options Amount ExerciseOfStockOptionsAmount	424000	usd
CY2023Q3	us-gaap	Investment Income Net InvestmentIncomeNet	367385	usd
CY2023Q3	mcvt	Depreciation In Value Of Investments DepreciationInValueOfInvestments	2175	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	19478006	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	14426607	usd
CY2022Q3	mcvt	Common Shares Issued In Public Offering Amount CommonSharesIssuedInPublicOfferingAmount	4041795	usd
CY2022Q3	mcvt	Common Shares Issued In Reverse Stock Split Rounding Amount CommonSharesIssuedInReverseStockSplitRoundingAmount	0	usd
CY2022Q3	mcvt	Common Shares Issued In Stock Based Compensation Amount CommonSharesIssuedInStockBasedCompensationAmount	66876	usd
CY2022Q3	mcvt	Common Shares Issued In Consideration For Expense Payment Amount CommonSharesIssuedInConsiderationForExpensePaymentAmount	159443	usd
CY2022Q3	mcvt	Undistributed Net Investment Loss UndistributedNetInvestmentLoss	-36126	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	18658595	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	17871560	usd
	mcvt	Stock Options Issued StockOptionsIssued	1460209	usd
	mcvt	Exercise Of Stock Options Amount ExerciseOfStockOptionsAmount	424000	usd
	mcvt	Net Investment Loss Net Of Tax Benefit NetInvestmentLossNetOfTaxBenefit	-348625	usd
	mcvt	Undistributed Net Realized Loss On Investment Transactions UndistributedNetRealizedLossOnInvestmentTransactions	-558629	usd
	mcvt	Appreciation In Value Of Investments AppreciationInValueOfInvestments	629491	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	19478006	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	13414049	usd
	mcvt	Common Shares Issued In Public Offering Amount CommonSharesIssuedInPublicOfferingAmount	4041795	usd
	mcvt	Common Shares Issued In Reverse Stock Split Rounding Amount CommonSharesIssuedInReverseStockSplitRoundingAmount	0	usd
	mcvt	Common Shares Issued In Stock Based Compensation Amount CommonSharesIssuedInStockBasedCompensationAmount	149315	usd
	mcvt	Common Shares Issued In Consideration For Expense Payment Amount CommonSharesIssuedInConsiderationForExpensePaymentAmount	159443	usd
	us-gaap	Investment Income Net InvestmentIncomeNet	777270	usd
	mcvt	Undistributed Net Realized Gain On Investment Transactions UndistributedNetRealizedGainOnInvestmentTransactions	133020	usd
	mcvt	Depreciation In Value Of Investments DepreciationInValueOfInvestments	-16297	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	18658595	usd
	mcvt	Net Increase Decrease In Net Assets Resulting From Operations NetIncreaseDecreaseInNetAssetsResultingFromOperations	-277763	usd
	mcvt	Net Increase Decrease In Net Assets Resulting From Operations NetIncreaseDecreaseInNetAssetsResultingFromOperations	893993	usd
	mcvt	Net Change In Unrealized Appreciation Depreciation On Investments NetChangeInUnrealizedAppreciationDepreciationOnInvestments	629491	usd
	mcvt	Net Change In Unrealized Appreciation Depreciation On Investments NetChangeInUnrealizedAppreciationDepreciationOnInvestments	-16297	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-558629	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	133020	usd
	mcvt	Purchases Of Investments PurchasesOfInvestments	-11900500	usd
	mcvt	Purchases Of Investments PurchasesOfInvestments	-13924333	usd
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	11124193	usd
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	10076483	usd
	mcvt	Issuance Of Stock Options IssuanceOfStockOptions	1460209	usd
	mcvt	Issuance Of Stock Options IssuanceOfStockOptions	0	usd
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-196000	usd
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	0	usd
	mcvt	Common Shares Issued For Expense Payment CommonSharesIssuedForExpensePayment	0	usd
	mcvt	Common Shares Issued For Expense Payment CommonSharesIssuedForExpensePayment	308758	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2700	usd
	us-gaap	Dividend Income Securities Operating Taxable DividendIncomeSecuritiesOperatingTaxable	38000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-21225	usd
	us-gaap	Increase Decrease In Interest And Dividends Receivable IncreaseDecreaseInInterestAndDividendsReceivable	31674	usd
	us-gaap	Increase Decrease In Interest And Dividends Receivable IncreaseDecreaseInInterestAndDividendsReceivable	-614949	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	0	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1900000	usd
	us-gaap	Increase Decrease In Accounts Payable And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities	-654278	usd
	us-gaap	Increase Decrease In Accounts Payable And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities	53903	usd
	mcvt	Increase Decrease In Income Taxes Payable IncreaseDecreaseInIncomeTaxesPayable	0	usd
	mcvt	Increase Decrease In Income Taxes Payable IncreaseDecreaseInIncomeTaxesPayable	-1185200	usd
	mcvt	Increase Decrease In Deferred Interest Income IncreaseDecreaseInDeferredInterestIncome	-70154	usd
	mcvt	Increase Decrease In Deferred Interest Income IncreaseDecreaseInDeferredInterestIncome	0	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-550781	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6429293	usd
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	0	usd
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	4041795	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	424000	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	2750000	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	8414000	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	2750000	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	6101000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	424000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6354795	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-126781	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-74498	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1089641	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1936148	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	962860	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1861650	usd
	us-gaap	Interest Paid Net InterestPaidNet	78010	usd
	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2023Q3	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	17577481	usd
CY2023Q3	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	17555601	usd
	us-gaap	Investment Company Incentive Fee To Average Net Assets InvestmentCompanyIncentiveFeeToAverageNetAssets	0.9013	pure
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	962860	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	962860	usd
	mcvt	Cash And Cash Equivalents Percent Of Net Assets CashAndCashEquivalentsPercentOfNetAssets	0.0494	pure
CY2023Q3	mcvt	Investments And Cash Cost InvestmentsAndCashCost	18540341	usd
CY2023Q3	mcvt	Investments And Cash Fair Value InvestmentsAndCashFairValue	18518461	usd
	mcvt	Investments And Cash Percentage Of Net Assets InvestmentsAndCashPercentageOfNetAssets	0.9507	pure
CY2022Q4	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	17359804	usd
CY2022Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	16708432	usd
CY2022	us-gaap	Investment Company Incentive Fee To Average Net Assets InvestmentCompanyIncentiveFeeToAverageNetAssets	0.9350	pure
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1089641	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	1089641	usd
CY2022	mcvt	Cash And Cash Equivalents Percent Of Net Assets CashAndCashEquivalentsPercentOfNetAssets	0.0610	pure
CY2022Q4	mcvt	Investments And Cash Cost InvestmentsAndCashCost	18449445	usd
CY2022Q4	mcvt	Investments And Cash Fair Value InvestmentsAndCashFairValue	17798073	usd
CY2022	mcvt	Investments And Cash Percentage Of Net Assets InvestmentsAndCashPercentageOfNetAssets	0.9960	pure
	us-gaap	Dividend Income Securities Operating Taxable DividendIncomeSecuritiesOperatingTaxable	346000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	201000	usd
CY2023Q3	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	397000	usd
	mcvt	Federeal Nol Description FederealNolDescription	federal NOL of approximately $277,000. The federal NOL may be carried forward to offset future taxable income, subject to applicable provisions of the Internal Revenue Code. Due to tax reform enacted in 2017, NOLs created after 2017 carry forward indefinitely. The estimated federal NOL that does not expire included in the total above is $277,000. States vary in their treatment of post-2017 NOLs. The state NOL of $200,000 is expected to be used by December 31, 2024. The remaining state NOL carryforwards may expire in 2038 if not used
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	870000	shares
	mcvt	Share Based Compensation Arrangement By Share Based Payment Award Options Exercised In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriodGross	-200000	shares
	mcvt	Weighted Average Grant Date Fair Value For Options Granted During The Period WeightedAverageGrantDateFairValueForOptionsGrantedDuringThePeriod	1242902	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0459	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.90	pure
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2022Q3	mcvt	Stockholders Equity Reverse Stock StockholdersEquityReverseStock	common shares on a 1-for-2.25 basis such that every 2.25 shares of common stock
CY2022Q3	us-gaap	Stock Issued During Period Shares Reverse Stock Splits StockIssuedDuringPeriodSharesReverseStockSplits	111111111	shares
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	7482	usd
CY2023Q3	mcvt	Operating Lease Interest OperatingLeaseInterest	-194	usd
CY2022Q3	mcvt	Operating Lease Interest OperatingLeaseInterest	456	usd
	mcvt	Investment Issuance Of Common Stock InvestmentIssuanceOfCommonStock	0.05
	mcvt	Investment Issuance Of Common Stock InvestmentIssuanceOfCommonStock	0.00
	mcvt	Investment Issuance Of Common Stock InvestmentIssuanceOfCommonStock	0.00
	mcvt	Investment Issuance Of Common Stock InvestmentIssuanceOfCommonStock	0.00
	mcvt	Investment Issuance Of Common Stock InvestmentIssuanceOfCommonStock	0.00
	mcvt	Investment Stock Based Compensation InvestmentStockBasedCompensation	0.00
	mcvt	Investment Stock Based Compensation InvestmentStockBasedCompensation	0.05
	mcvt	Investment Stock Based Compensation InvestmentStockBasedCompensation	0.00
	mcvt	Investment Stock Based Compensation InvestmentStockBasedCompensation	0.00
	mcvt	Investment Stock Based Compensation InvestmentStockBasedCompensation	0.00
	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.00
	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.00
	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.00
	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.05
	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.00
	mcvt	Other Changes In Equity Per Share Data OtherChangesInEquityPerShareData	-0.09
	mcvt	Other Changes In Equity Per Share Data OtherChangesInEquityPerShareData	0.02
	mcvt	Other Changes In Equity Per Share Data OtherChangesInEquityPerShareData	0.00
	mcvt	Other Changes In Equity Per Share Data OtherChangesInEquityPerShareData	0.00
	mcvt	Other Changes In Equity Per Share Data OtherChangesInEquityPerShareData	0.00
	us-gaap	Investment Company Distribution To Shareholders Per Share InvestmentCompanyDistributionToShareholdersPerShare	0.00
	us-gaap	Investment Company Distribution To Shareholders Per Share InvestmentCompanyDistributionToShareholdersPerShare	0.00
	us-gaap	Investment Company Distribution To Shareholders Per Share InvestmentCompanyDistributionToShareholdersPerShare	0.23
	us-gaap	Investment Company Distribution To Shareholders Per Share InvestmentCompanyDistributionToShareholdersPerShare	0.00

Files In Submission

Name	View Source	Status
mcvt-20230930_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
0001654954-23-014555-index-headers.html	Edgar Link	pending
0001654954-23-014555-index.html	Edgar Link	pending
0001654954-23-014555.txt	Edgar Link	pending
0001654954-23-014555-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
mcvt-20230930.xsd	Edgar Link	pending
mcvt_10q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
mcvt_10q_htm.xml	Edgar Link	completed
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
mcvt-20230930_def.xml	Edgar Link	unprocessable
mcvt-20230930_lab.xml	Edgar Link	unprocessable
mcvt-20230930_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MCVT
Mill City Ventures III, Ltd Stock $mcvt

2023 Q4 Form 10-Q Financial Statement

#000165495423014555 Filed on November 17, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MCVT Mill City Ventures III, Ltd Stock $mcvt

2023 Q4 Form 10-Q Financial Statement

#000165495423014555 Filed on November 17, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MCVT
Mill City Ventures III, Ltd Stock $mcvt